Omeros Corporation announced preliminary results from the second cohort of critically ill COVID-19 patients treated with narsoplimab in Bergamo, Italy.
[Omeros Corporation]
Sorry, but the selected Zotpress account can't be found.
Home Newsletters Endothelial Cell News Omeros Announces Preliminary Results from Additional Critically Ill COVID-19 Patients Treated with...
